FDA Publishes Final Order on AI CAD Petition
FDA issues final order denying AI CAD petition after reviewing public comments, including feedback submitted by ACR.
Read more
ACR® CEO Dana H. Smetherman, MD, MPH, MBA, FACR, and ACR Board of Chancellors Vice Chair Christoph Wald, MD, PhD, MBA, FACR, urged World Health Expo (WHX) attendees to take advantage of new ACR International programs and explained how the College can support radiology professionals and patients worldwide.
Their Feb. 10 sessions in Dubai spotlighted ACR international membership options, quality and safety initiatives and an artificial intelligence (AI) portfolio designed to promote high-quality imaging and safe AI adoption across global health systems.
Dr. Wald’s presentation traced radiology AI evolution and spotlighted ACR leadership in guiding ethical, effective and clinically impactful AI implementation. Through the ACR Data Science Institute®, ACR launched initiatives including the Define-AI Directory, AI-LAB™, AI Central, ARCH-AI quality recognition and the Assess-AI registry. These programs support education, validation, ethics and post-deployment monitoring of imaging AI. In 2025, ACR launched the Informatics International membership and international ARCH-AI recognition.

For more information, contact Shawn Farley, ACR Senior Director of Public Affairs.
FDA Publishes Final Order on AI CAD Petition
FDA issues final order denying AI CAD petition after reviewing public comments, including feedback submitted by ACR.
Read moreHouse Panel Reviews ACR Priorities on Medicare Reform
ACR-backed Medicare reforms advance imaging modernization, physician payment stability and reduced administrative burden.
Read moreACR Urges CMS Transparency in 2027 Physician Fee Rule
ACR submitted comments on the 2027 Medicare Physician Fee Schedule, calling for transparency in payment policy changes.
Read more